JSC “Lekhim” (Kyiv) saw its net profit decline by 65.5% in 2025 compared to 2024, down to 24.424 million UAH.
According to the company’s disclosure in the NSSMC’s information disclosure system, net sales revenue in 2025 increased by 22.2% to UAH 2.191 billion.
JSC “Lekhim” is the holding company of the ‘Lekhim’ group, which includes PJSC “Technolog” (Kyiv region), JSC “Lekhim-Kharkiv,” LLC “Lekhim-Obukhiv” (Kyiv region), UAB “LEKHIM-VILNIUS” (Lithuania), and IP “LEKHIM” (Uzbekistan).
It ranks among the top 10 largest pharmaceutical manufacturers in Ukraine.
